ISIN | CH0457194857 |
---|---|
Valor Number | 45719485 |
Bloomberg Global ID | AXAETES SW |
Fund Name | AXA (CH) Strategy Fund - Economic Trends Equity CHF S Distribution Yearly CHF |
Fund Provider |
Axa Leben AG
Phone: +41 0800 809 809 Web: https://www.axa-winterthur.ch |
Fund Provider | Axa Leben AG |
Representative in Switzerland | |
Distributor(s) |
AXA Investment Managers Schweiz AG Zürich Phone: +41 43 299 12 12 |
Asset Class | Equities |
EFC Category | Equity Europe |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of this subfund is to generate growth in value and an appropriate return in CHF from a diversifed and actively managed portfolio of equities, equity-like securities and derivatives with a focus on the (i) Swiss, Liechtenstein and (ii) European capital markets. In addition, the investment process is geared around theme-based trends. |
Peculiarities |
Current Price * | 132.76 CHF | 31.03.2025 |
---|---|---|
Previous Price * | 135.41 CHF | 28.03.2025 |
52 Week High * | 139.37 CHF | 13.02.2025 |
52 Week Low * | 124.70 CHF | 06.08.2024 |
NAV * | 132.76 CHF | 31.03.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 167,261,076 | |
Unit/Share Assets *** | 167,261,076 | |
Trading Information SIX |
YTD Performance | +5.29% |
30.12.2024 - 31.03.2025
30.12.2024 31.03.2025 |
---|---|---|
1 month | -3.52% |
28.02.2025 - 31.03.2025
28.02.2025 31.03.2025 |
3 months | +5.24% |
03.01.2025 - 31.03.2025
03.01.2025 31.03.2025 |
6 months | +0.66% |
30.09.2024 - 31.03.2025
30.09.2024 31.03.2025 |
1 year | +3.59% |
02.04.2024 - 31.03.2025
02.04.2024 31.03.2025 |
2 years | +8.95% |
31.03.2023 - 31.03.2025
31.03.2023 31.03.2025 |
3 years | +8.56% |
31.03.2022 - 31.03.2025
31.03.2022 31.03.2025 |
5 years | +54.90% |
31.03.2020 - 31.03.2025
31.03.2020 31.03.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
ASML Holding NV | 6.00% | |
---|---|---|
Roche Holding AG | 5.94% | |
Nestle SA | 5.55% | |
Novartis AG Registered Shares | 4.83% | |
Deutsche Telekom AG | 3.50% | |
Sandoz Group AG Registered Shares | 3.42% | |
ABB Ltd | 3.25% | |
UBS Group AG | 2.98% | |
BNP Paribas Act. Cat.A | 2.98% | |
Compagnie de Saint-Gobain SA | 2.88% | |
Last data update | 30.11.2024 |
TER | 0.35% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.70% |
Ongoing Charges *** | 0.35% |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |